Innovent Biologics Inc.
IVBXF | OTC
$10.53
+$0.63 (+6.36%)
Nov 2, 2026, 10:30 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q4 2025 Dec 31, 2025 | Q2 2025 Jun 30, 2025 | Q4 2024 Dec 31, 2024 | Q2 2024 Jun 30, 2024 | Q4 2023 Dec 31, 2023 | Q2 2023 Jun 30, 2023 | Q4 2022 Dec 31, 2022 | Q2 2022 Jun 30, 2022 | Q4 2021 Dec 31, 2021 | Q2 2021 Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 1.23B | 813.91M | 1.13B | -94.63M | -1.28B | -1.03B | -1.37B | -2.18B | -2.68B | -2.73B | -1.39B |
Depreciation & Amortization | 329.73M | 615.45M | 525.56M | 438.52M | 381.81M | 370.77M | 339.48M | 276.79M | 237.6M | 202.17M | 118.71M |
Stock-Based Compensation | 384.84M | 342.38M | 601.18M | 556.52M | 644.93M | 574.2M | 435.31M | 469.49M | 523.71M | 501.57M | 486.88M |
Other Working Capital | 9.26B | 8.9B | 109.72M | 447.71M | 550.61M | 566.77M | -411.58M | -313.45M | 858.87M | 864.46M | 444.09M |
Other Non-Cash Items | -1.14B | -683.69M | -799.78M | 176.65M | 100.82M | -264.33M | -1.06B | -460.11M | -185.08M | 272.01M | 985.89M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | 96.89M | -761.46M | -757.24M | 101.11M | 822.5M | 882.35M |
Change in Working Capital | 8.86B | 7.69B | -596.19M | 449.82M | 708.89M | 495.09M | -85.43M | -25.71M | 283.34M | -271.84M | -777.21M |
Operating Cash Flow | 9.66B | 10.09B | 1.94B | 1.29B | 555.07M | 147.81M | -1.73B | -1.92B | -1.82B | -2.02B | -579.52M |
Capital Expenditures | -228.17M | -269.59M | -307.58M | -965.67M | -1.22B | -1.12B | -1.07B | -896.9M | -1.15B | -1.07B | -803.22M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -16.84B | -16.84B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 9.97B | 9.97B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 144.57M | 144.57M | -611.72M | -465.9M | -1.06B | 120.72M | -23.75M | -538.29M | -955.41M | -1.63B | -3.65B |
Investing Cash Flow | -7.17B | -6.75B | -193.17M | -1.17B | -2.28B | -998.66M | -1.09B | -1.44B | -2.1B | -2.7B | -4.45B |
Debt Repayment | -572.7M | -572.7M | n/a | -330.13M | -330.13M | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -5.13M | 157.83M | -182.86M | -276.5M | 2.41B | 2.59B | 2.91B | 2.89B | 723.44M | 5B | 7.23B |
Financial Cash Flow | 4.05B | 4.82B | 420.67M | -606.63M | 2.08B | 2.59B | 2.91B | 2.89B | 723.44M | 5B | 7.23B |
Net Cash Flow | 992.63M | 8.88B | 6.18B | -2.23B | 190.85M | 864.76M | -9.89M | -171.62M | -1.56B | -539.5M | 166.96M |
Free Cash Flow | 9.43B | 9.82B | 1.63B | 321.36M | -665.93M | -971.58M | -2.8B | -2.82B | -2.96B | -3.09B | -1.38B |
Adj. Free Cash Flow | 9.05B | 9.48B | 1.03B | -235.16M | -1.31B | -1.55B | -3.24B | -3.29B | -3.49B | -3.59B | -1.87B |
Maintenance CapEx | n/a | n/a | n/a | -187.11M | -655.02M | -784.05M | -1.5B | -1.31B | -846.35M | -717.31M | n/a |
Growth CapEx | -535.75M | -1.24B | -1.53B | -1.9B | -1.63B | -1.23B | -710.74M | -648.28M | -1.1B | -837.35M | -1.06B |
Owner Earnings | 11.6B | 11.38B | 2.49B | 1.25B | -1.83B | -2.56B | -5.05B | -5.26B | -3.24B | -3.05B | -2.07B |
Add to Watchlist
Select watchlists to add or remove IVBXF